
9th National Conference on Anticoagulant Therapy
May 3-5, • 2007 Chicago Marriott Downtown
| |
|
Conference Agenda, May 3 5, 2007 |
| |
Thursday, May 3 |
|
9:00am - 7:00pm
|
Conference Registration |
|
|
9:00 am – 12:00 pm |
|
CACP Exam* |
National Certification Board of Anticoagulation Providers |
|
|
|
|
|
|
Basic Science Sessions |
|
|
|
1:00 1:45 pm |
|
Understanding Genetics in the Context of Thrombophilia |
|
|
|
Elizabeth Varga, MS |
| |
|
|
1:45 – 2:30 |
|
The Role of Genetics in Warfarin Dosing |
|
|
|
Brian Gage, MD |
|
|
|
|
| 2:30 – 3:00 |
|
Genetic Counseling |
| |
|
Elizabeth Varga, MS |
| |
|
|
3:00 – 3:30 |
|
Break |
|
|
|
| |
|
Round Table Discussion |
|
|
|
| 3:30 – 5:00 |
|
Implementation of Home INR Monitoring |
|
|
Alan Jacobson, MD |
|
|
Mark Wurster, MD |
|
|
Diane Wirth, ANP |
|
|
Nancy Shapiro, Pharm D |
| |
|
Industry Representatives |
|
|
|
6:30 – 8:30 |
|
Welcome Reception |
|
* To register for the CACP exam, please visit www.ncbap.org |
|
|
|
Friday, May 4 |
|
|
|
7:00 – 8:30 am |
|
Breakfast |
| |
|
|
|
|
Plenary Session |
8:30 8:45 |
|
Introduction |
| |
|
Jack Ansell, MD |
|
|
|
8:45 – 9:30 |
|
Mechanical Heart Valves: |
| |
|
Technological Advances and Recommended Antithrombotic Therapy |
|
|
Robert Emery, MD |
|
|
|
9:30 – 10:15 |
|
Atrial Fibrillation: |
| |
|
Recommended Antithrombotic Therapy and Treatment of its Major Complication Intracranial Hemorrhage |
|
|
Robert Hart, MD |
|
|
|
10:15 10:45 |
|
Break |
|
|
|
10:45 11:30 |
|
Cancer & Venous Thromboembolism: |
| |
|
Treatment, Prophylaxis & Survival |
| |
|
Agnes Lee, MD |
|
|
|
11:30 – 12:15 pm |
|
Treatment of DVT: |
| |
|
How Long Is Long Enough and How Do You Predict Recurrence |
|
|
Giancarlo Agnelli, MD |
|
|
|
12:15 12:45 |
|
A Patients Story |
|
|
|
12:45 2:00 |
|
Lunch |
|
|
|
2:00 3:30 |
|
Meet The Expert Sessions |
|
|
- Determinants and Measures of Quality in Oral Anticoagulation Therapy |
|
|
Scott Kaatz, MD |
|
|
|
|
|
- Establishing and Staffing an Inpatient Anticoagulation Service |
|
|
Geno Merli, MD |
|
|
John Viercinski, RPh |
|
|
|
- Dietary Supplements, Herbs and Oral Anticoagulants |
|
|
Ann Wittkowski, PharmD |
|
|
|
|
|
- Case Vignettes** |
|
|
Wendy Leong, PharmD |
|
|
|
|
|
- Managing Anticoagulant-Related Bleeding |
|
|
Amir Jaffer, MD |
|
|
|
3:30 – 6:00 |
|
Poster Presentations of Original Research |
|
|
|
** Conference participants are invited to submit written reports of interesting/challenging cases. The best 6 cases will be selected and presented at the conference. Please email case to Elizabeth.goldstein@bmc.org by April 1. Word limit: 250 words. |
|
|
|
|
|
|
Saturday, May 5 |
|
|
|
|
Meet The Expert Sessions |
| 8:00 – 9:30 am |
|
(continental breakfast served) |
| |
|
|
|
|
-Determinants and Measures of Quality in Oral Anticoagulation Therapy |
| |
|
Scott Kaatz, MD |
|
|
|
|
|
- Establishing and Staffing an Inpatient Anticoagulation Service |
|
|
Geno Merli, MD |
|
|
John Viercinski, RPh |
|
|
|
|
|
- Dietary Supplements, Herbs and Oral Anticoagulants |
|
|
Ann Wittkowski, PharmD |
|
|
|
|
|
- Case Vignettes** |
|
|
Wendy Leong, PharmD |
|
|
|
|
|
- Managing Anticoagulant-Related Bleeding |
|
|
Amir Jaffer, MD |
|
|
|
9:30 – 9:45 |
|
Break |
|
|
|
| |
|
Plenary Session
|
9:45 – 10:00 |
|
Update: Anticoagulation Forum Leadership: Change of Guard |
|
|
Jack Ansell, MD |
|
|
David Garcia, MD |
|
|
|
10:00 10:15 |
|
Update: NCBAP |
|
|
Lynn Oertel, RN |
|
|
|
10:15 -11:00 |
|
Innovations in Anticoagulation Management: the VA Leading the Way |
|
|
David Matchar, MD |
|
|
Rebecca Beyth, MD |
|
|
|
11:00 – 11:45 |
|
New Oral Xa and IIa Inhibitors: Updates on Clinical Trial Results |
|
|
Harry Büller, MD |
|
|
|
11:45 12:00 |
|
Wrap Up |
|
|
|
12:00 – 1:30 |
|
Lunch |
|
|
|
1:30 4:00 |
|
Improving Patient Quality of Life |
|
|
Hosted by the National Alliance for Thrombosis & Thrombophilia (NATT) and the International Self-Monitoring Association of Oral Anticoagulated Patients (ISMAAP).
Presentations and an interactive discussion between thrombosis and treatment advocacy groups, health care providers, and patients. |
|
|
|
| |
| |
|
|